This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (20)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Multiple Sclerosis/ Demyelinating Disease  • Neuropathology  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Jagannadha R. Avasarala, MD, PhD; Anne H. Cross, MD; John L. Trotter, MD

Arch Neurol. 2001;58:2044-2045.

The natural course of disease in multiple sclerosis varies. Multiple sclerosis that is clinically apparent but causes minimal disability over time has been labeled benign multiple sclerosis. The ability to predict the subsequent clinical course of multiple sclerosis on the basis of clinical and other supportive data at presentation would be invaluable. In this article we report our findings based on a retrospective analysis of 1800 patients diagnosed as having multiple sclerosis, of which 44 patients met our inclusion criteria. There was a suggestion that a low or absent number of oligoclonal bands in the cerebrospinal fluid at the time of diagnosis predicts a better prognosis. However, quantification of oligoclonal bands in cerebrospinal fluid remains an insensitive prognostic indicator and must not be used to influence decisions regarding therapeutic options.

From the Department of Neurology, Washington University School of Medicine, St Louis, Mo.
Dr Trotter died unexpectedly on July 12, 2001.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(12):2078-2079.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Optimizing Outcomes in Multiple Sclerosis - A Consensus Initiative
Coyle et al.
Mult Scler 2009;15:S5-S35.
ABSTRACT  

Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis
Thangarajh et al.
Mult Scler 2008;14:1208-1213.
ABSTRACT  

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis
Lucchinetti et al.
Brain 2008;131:1759-1775.
ABSTRACT | FULL TEXT  

Higher IgG index found in African Americans versus Caucasians with multiple sclerosis
Rinker et al.
Neurology 2007;69:68-72.
ABSTRACT | FULL TEXT  

Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis.
Rinker et al.
Neurology 2006;67:1288-1290.
ABSTRACT | FULL TEXT  

Between-Laboratory Variability in Oligoclonal IgG Band Numbering
Franciotta et al.
Clin. Chem. 2005;51:270-272.
FULL TEXT  

Sample size estimates for determining treatment effects in high-risk patients with early relapsing-remitting multiple sclerosis
Scott et al.
Mult Scler 2003;9:289-292.
ABSTRACT